27.85
Schlusskurs vom Vortag:
$28.26
Offen:
$27.84
24-Stunden-Volumen:
788.08K
Relative Volume:
2.70
Marktkapitalisierung:
$1.17B
Einnahmen:
$384.90M
Nettoeinkommen (Verlust:
$-851.00K
KGV:
-1,392.50
EPS:
-0.02
Netto-Cashflow:
$12.83M
1W Leistung:
-7.35%
1M Leistung:
-9.17%
6M Leistung:
+6.22%
1J Leistung:
+37.40%
Artivion Inc Stock (AORT) Company Profile
Firmenname
Artivion Inc
Sektor
Branche
Telefon
(770) 419-3355
Adresse
1655 ROBERTS BOULEVARD N W, KENNESAW
Vergleichen Sie AORT mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
AORT
Artivion Inc
|
27.85 | 1.17B | 384.90M | -851.00K | 12.83M | -0.02 |
![]()
ABT
Abbott Laboratories
|
134.95 | 234.06B | 41.95B | 13.40B | 6.49B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
104.39 | 154.06B | 16.75B | 1.85B | 2.37B | 1.25 |
![]()
SYK
Stryker Corp
|
387.92 | 148.02B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
90.17 | 115.71B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
72.76 | 42.91B | 5.72B | 4.17B | 490.10M | 6.97 |
Artivion Inc Stock (AORT) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-10-23 | Eingeleitet | JMP Securities | Mkt Outperform |
2022-09-27 | Bestätigt | Lake Street | Buy |
2022-08-08 | Eingeleitet | Lake Street | Buy |
2022-03-03 | Eingeleitet | Stifel | Buy |
Artivion Inc Aktie (AORT) Neueste Nachrichten
Earnings call transcript: Artivion Q4 2024 misses revenue forecast, stock drops - Investing.com UK
Artivion Inc Reports Q4 2024 Earnings: EPS of $(0.39) Misses Est - GuruFocus.com
Artivion (AORT) Reports Break-Even Earnings for Q4 - Yahoo Finance
Artivion: Q4 Earnings Snapshot - The Washington Post
Artivion shares tumble on revenue miss and weak guidance - Investing.com India
Artivion shares tumble on revenue miss and weak guidance By Investing.com - Investing.com Nigeria
Earnings Flash (AORT) ARTIVION INC. Posts Q4 Adjusted EPS $0.00, vs. FactSet Est of $0.04 - Marketscreener.com
Earnings Flash (AORT) ARTIVION INC. Reports Q4 Revenue $97.3M, vs. FactSet Est of $100.9M - Marketscreener.com
Artivion Reports Fourth Quarter and Full Year 2024 Financial Results - TradingView
Artivion (NYSE:AORT) Misses Q4 Sales Targets - Financial Content
Artivion (AORT) Q4 Earnings: What To Expect - The Globe and Mail
New York State Teachers Retirement System Reduces Holdings in Artivion, Inc. (NYSE:AORT) - Defense World
Earnings To Watch: Artivion Inc (AORT) Reports Q4 2024 Result - GuruFocus.com
Artivion Inc expected to post a loss of 6 cents a shareEarnings Preview - TradingView
Artivion (NYSE:AORT) Q3 Earnings: Leading The Medical Devices & SuppliesCardiology, Neurology, Vascular Pack - Investing.com Canada
Is Now An Opportune Moment To Examine Artivion, Inc. (NYSE:AORT)? - Simply Wall St
Artivion (AORT) Projected to Post Quarterly Earnings on Thursday - Defense World
$536.73 Bn Organ Preservation Solution Market Strategies and Opportunities to 2033: New R&D Center to Revolutionize Organ Preservation Techniques and Enhance Global Healthcare Solutions - GlobeNewswire Inc.
Cardiac Tissue Engineering Market 2025 Top Business Strategy, Growth Factors, Healthy CAGR with Segments & Forecast with Top 5 Key Players Analysis - The Globe and Mail
SG Americas Securities LLC Has $206,000 Stock Holdings in Artivion, Inc. (NYSE:AORT) - MarketBeat
Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2024 Financial Results - Longview News-Journal
Wound Closure Market Size to Hit USD 26.63 Billion by 2032, Growing at a CAGR of 6.47% - GlobeNewswire Inc.
Artivion (AORT) Q4 Earnings Call: Strategic Growth Update & Financial Metrics RevealMark Your Calendar - StockTitan
SG Americas Securities LLC Sells 9,689 Shares of Artivion, Inc. (NYSE:AORT) - Defense World
Artivion, Inc. (NYSE:AORT) Shares Acquired by Calamos Advisors LLC - MarketBeat
Artivion (NYSE:AORT) Receives Buy Rating from Needham & Company LLC - MarketBeat
Needham & Company LLC Reiterates Buy Rating for Artivion (NYSE:AORT) - Defense World
Where Artivion Stands With Analysts - Benzinga
Oppenheimer maintains Artivion Outperform with $32 target - MSN
Oppenheimer maintains Artivion stock with $32 target By Investing.com - Investing.com Canada
Oppenheimer maintains Artivion stock with $32 target - Investing.com
Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 61st Society of Thoracic Surgery Annual Meeting - PR Newswire
Artivion, Inc. (NYSE:AORT) Holdings Raised by JPMorgan Chase & Co. - MarketBeat
JPMorgan Chase & Co. Has $2.61 Million Stock Holdings in Artivion, Inc. (NYSE:AORT) - Defense World
Is Artivion, Inc. (AORT) Among Billionaire Joseph Edelman’s Long-Term Stock Picks? - MSN
Artivion (NYSE:AORT) Hits New 1-Year HighTime to Buy? - MarketBeat
CryoLife Stock Soars to 52-Week High, Hits $30.62 - Investing.com
CryoLife Stock Soars to 52-Week High, Hits $30.62 By Investing.com - Investing.com UK
3 US Stocks Estimated To Be Trading Below Their Intrinsic Value In January 2025 - Simply Wall St
GAMMA Investing LLC Purchases 497 Shares of Artivion, Inc. (NYSE:AORT) - Defense World
Why Investors Shouldn't Be Surprised By Artivion, Inc.'s (NYSE:AORT) P/S - Simply Wall St
New Strong Buy Stocks for January 7th - MSN
Artivion, Inc. (NYSE:AORT) Shares Sold by Principal Financial Group Inc. - Defense World
Franklin Resources Inc. Boosts Holdings in Artivion, Inc. (NYSE:AORT) - Defense World
Geode Capital Management LLC Has $23.46 Million Stock Position in Artivion, Inc. (NYSE:AORT) - Defense World
Jane Street Group LLC Has $1.63 Million Stock Holdings in Artivion, Inc. (NYSE:AORT) - MarketBeat
Barclays PLC Purchases 54,996 Shares of Artivion, Inc. (NYSE:AORT) - Defense World
Finanzdaten der Artivion Inc-Aktie (AORT)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):